Board Appointment

Anthropic has appointed Chris Liddell, a former White House official and executive, to its board. This strategic move aims to help the AI startup navigate complex regulatory and political landscapes surrounding generative AI. Liddell’s extensive experience in government and corporate governance is expected to be invaluable as Anthropic, known for its Claude AI models, seeks to balance technological advancement with responsible development and engage with policymakers.

Virginia National Bankshares Corporation welcomes Robert Lee Burrows, Jr. to its Board of Directors, effective February 25, 2026. With over four decades in financial services, Burrows founded Banks Street Partners and played key roles in establishing several other financial institutions. His extensive experience in investment banking and corporate governance is expected to significantly contribute to the company’s growth.

Sranan Gold has appointed veteran mining engineer Ron Halas to its board. Halas brings over 35 years of global mining experience, including significant on-the-ground work in Suriname, where he previously held executive roles. His expertise spans project evaluation, development, and operations, with a proven track record of advancing projects through critical stages. This appointment is expected to bolster Sranan Gold’s technical capabilities and strategic execution as they focus on their Surinamese assets.

LiTHOS Group Ltd. announced leadership changes effective January 14, 2026. CFO Jennie Choboter has resigned, creating a temporary void in financial leadership. Concurrently, Elyssia Patterson, CEO of Lycan Capital Corp., has joined the Board of Directors. Patterson’s extensive experience with CSE-listed companies is expected to strengthen governance, though the search for a new CFO will be key to maintaining investor confidence and operational stability.

Tetra Tech has appointed seasoned environmental services executive, Jeffrey R. Feeler, to its Board of Directors, effective December 29, 2025. Feeler, formerly CEO of US Ecology, brings extensive operational leadership, financial strategy, and corporate governance experience. His appointment is expected to bolster Tetra Tech’s “Leading with Science®” approach in water, environment, and sustainable infrastructure sectors.

CEA Industries (Nasdaq: BNC) appointed Annemarie Tierney, founder of Liquid Advisors, to its Board of Directors effective Nov 26 2025. Tierney brings extensive experience in digital‑asset regulation, U.S. securities law, market structure and corporate governance from roles at the SEC, Nasdaq Private Market, NYSE and law firms, and holds FINRA Series 7, 63, 24 licenses. Her addition enhances BNC’s regulatory alignment and institutional‑ready governance as the company expands its Binance Coin treasury.

Guardian Metal Resources (GMTLF) appointed Michael Xavier Schlumpberger as an Independent Non-executive Director, effective November 11, 2025, replacing retiring director Mick Billing. Schlumpberger will serve on the Audit and Remuneration Committees. This appointment supports Guardian Metal’s strategy to revive U.S. tungsten production, a critical metal for defense, energy, technology and industrial sectors. Regulatory details regarding Schlumpberger’s directorships are disclosed in the announcement.

OraSure Technologies appointed Steven K. Boyd to its Board as a Class II director and named Jack Kenny as Board Chair, succeeding Mara Aspinall. The board now has seven directors, six independent, with three new independent directors added in the past three years. These changes aim to drive profitable growth, innovation, and shareholder value, building on a strengthened balance sheet and improved profitability by focusing on diagnostics and sample management. Boyd’s experience in healthcare investment and Kenny’s diagnostics background are expected to contribute to the company’s strategic direction.

Therma Bright (TBRIF) appointed Michael Raimondo, a 30-year healthcare sales veteran, to its Board of Directors on October 10, 2025. Raimondo, previously on the advisory board, brings experience from Abbott and over $500 million in sales contracts. He will focus on scaling Venowave sales through an internal sales team and reseller channels. Concurrently, Alex Saringer resigned from the Board. Raimondo also holds positions at Delphine Diagnostics and The Potentia Group.